SCOPUS 정보 검색 플랫폼

American Journal of Clinical Pathology

Volumn 120, Issue 6, 2003, Pages 938-943

Clinical Pathology Consultation Improves Coagulation Factor Utilization in Hospitalized Adults

(4) Marques, Marisa B a Fritsma, George A a Long, J Alan a Adler, Brian K b

a University of Alabama at Birmingham (United States)

b University of Alabama at Birmingham (United States)

Author keywords

Clinical pathology consultation; Coagulation factor concentrates; Hemophilia; Treatment cost

Indexed keywords

BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 INHIBITOR; BLOOD CLOTTING FACTOR 9; PROTHROMBIN COMPLEX; VON WILLEBRAND FACTOR;

ARTICLE; BLOOD TRANSFUSION; CLINICAL ARTICLE; CONSULTATION; CONTROLLED STUDY; COST; HEALTH CARE COST; HEMOPHILIA A; HOSPITALIZATION; HUMAN; PATHOLOGY; PLASMA FACTOR; PRIORITY JOURNAL; RESOURCE ALLOCATION;

EID: 0345690078 PISSN: 00029173 EISSN: None Source Type: Journal
DOI: 10.1309/RRE3DB8WRR955WFL Document Type: Article

Times cited : (9)

References (9)

1
- 0036799318
- Can costs of hemophilia products be curtailed? Not as we do business today
- Aledort LM. Can costs of hemophilia products be curtailed? not as we do business today. Thromb Haemost. 2002;88:541-553.
- (2002) Thromb Haemost , vol.88 , pp. 541-553
- Aledort, L.M.¹

2
- 0034585517
- Choice of replacement therapy for hemophilia: Recombinant products only?
- Mannucci PM, Giangrande PL. Choice of replacement therapy for hemophilia: recombinant products only? Hematol J. 2000;1:72-76.
- (2000) Hematol J , vol.1 , pp. 72-76
- Mannucci, P.M.¹ Giangrande, P.L.²

3
- 0033220609
- Treatment of patients with inhibitors: Cost issues
- Goudemand J. Treatment of patients with inhibitors: cost issues. Haemophilia. 1999;5:397-401.
- (1999) Haemophilia , vol.5 , pp. 397-401
- Goudemand, J.¹

4
- 0033452856
- Probabilities, costs, and outcomes: Methodological issues in modeling haemophilia treatment
- Bohn RL, Colowick AB, Avorn J. Probabilities, costs, and outcomes: methodological issues in modeling haemophilia treatment. Haemophilia. 1999;5:374-377.
- (1999) Haemophilia , vol.5 , pp. 374-377
- Bohn, R.L.¹ Colowick, A.B.² Avorn, J.³

5
- 0033126348
- Economic aspects of haemophilia care
- Aledort LM. Economic aspects of haemophilia care [editorial]. Haemophilia. 1999;5:373.
- (1999) Haemophilia , vol.5 , pp. 373
- Aledort, L.M.¹

6
- 0034444579
- Economics of hemophilia care
- Aledort LM. Economics of hemophilia care. Haemostasis. 2000;30:333-336.
- (2000) Haemostasis , vol.30 , pp. 333-336
- Aledort, L.M.¹

7
- 0029802698
- What many of us are doing or should be doing in clinical pathology: A list of the activities of the pathologist in the clinical laboratory
- Laposata M. What many of us are doing or should be doing in clinical pathology: a list of the activities of the pathologist in the clinical laboratory. Am J Clin Pathol. 1996;106:571-573.
- (1996) Am J Clin Pathol , vol.106 , pp. 571-573
- Laposata, M.¹

8
- 0029134781
- Value-added laboratory medicine in an era of managed care
- McDonald JM, Smith JA. Value-added laboratory medicine in an era of managed care. Clin Chem. 1995;41:1256-1262.
- (1995) Clin Chem , vol.41 , pp. 1256-1262
- McDonald, J.M.¹ Smith, J.A.²

9
- 0030007766
- The role of the transfusion medicine consultant
- Popovsky MA, Triulzi D. The role of the transfusion medicine consultant. Am J Clin Pathol. 1996;105:798-801.
- (1996) Am J Clin Pathol , vol.105 , pp. 798-801
- Popovsky, M.A.¹ Triulzi, D.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.